Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CLOSE
X
HOME CAPABILITIES Why Single Cell SNV SNV + CNV DNA + Protein Applications Oncology Research Multiple Myeloma AML MRD Precision Medicine Genome Editing Genome Integrity Assay Biomarker Development Cell and Gene Therapy Products & Services Tapestri Platform Panels Pharma Assay Development PAD for Cell & Gene Therapy PAD for Drug Development
RESOURCES BLOG PODCAST COMPANY About Us Careers Newsroom Events Distributors & Service Providers SUPPORT CENTER CONTACT PORTAL
X
Home Events 62nd American Society of Hematology (ASH) Annual Meeting and Exposition 2020
Events

62nd American Society of Hematology (ASH) Annual Meeting and Exposition 2020

Virtual
Channel: 14
December 5 - December 6, 2020
Register

Attend the world’s most comprehensive hematology event of the year for an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates on the most critical topics in hematology.

We encourage you to tune into below scientific presentations highlighting the advancements in hematology using single-cell DNA and multi-omics applications.

Visit Mission Bio’s virtual booth during the meeting to learn more about single-cell multi-omics or to get an overview of the latest application datasets.

SESSION
BAX-Mutated Clonal Hematopoiesis in Patients on Long-Term Venetoclax for Relapsed/Refractory Chronic Lymphocytic Leukemia
DATE & TIME
12.05.2020
3:00PM Pacific Time
LOCATION
Channel: 14
PUBLICATION
NUMBER
264
PRESENTERS
Piers Blombery, MBBS, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
ABSTRACT
604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases
SESSION
Clonal Expansion of Mutant p53 Clones By MDM2 Inhibition in Acute Myeloid Leukemias
DATE & TIME
12.06.2020
7:00AM Pacific Time
LOCATION
Poster Hall
PUBLICATION
NUMBER
1880
PRESENTERS
Yuki Nishida, MD, PhD, MD Anderson Cancer Center, Houston, Texas
ABSTRACT
604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II
SESSION
Molecular Characterization of Clinical Response and Relapse in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib and Azacitidine
DATE & TIME
12.06.2020
7:00AM Pacific Time
LOCATION
Poster Hall
PUBLICATION
NUMBER
1943
PRESENTERS
Scott R. Daigle, MS, Agios Pharmaceuticals, Inc, Cambridge, Massachusetts
ABSTRACT
615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II
SESSION
Signaling Gene Mutations Are Characterized By Diverse Patterns of Expansion and Contraction during Progression from MDS to Secondary AML
DATE & TIME
12.06.2020
12:45PM Pacific Time
LOCATION
Channel 15
PUBLICATION
NUMBER
409
PRESENTERS
Andrew J Menssen, BA, Washington University School of Medicine, St. Louis, Missouri
ABSTRACT
636. Myelodysplastic Syndromes — Basic and Translational Studies
SESSION
High Clonal Complexity of Resistance Mechanisms Occurring at Progression after Single-Agent Targeted Therapy Strategies in Chronic Lymphocytic Leukemia
DATE & TIME
12.07.2020
7:00AM Pacific Time
LOCATION
Channel 8
PUBLICATION
NUMBER
524
PRESENTERS
Ella Thompson, PhD, BSc, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
ABSTRACT
605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: Molecular pharmacology and drug resistance mechanisms in lymphoproliferative disorders
SESSION
Longitudinal Molecular Profiling in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib
DATE & TIME
12.07.2020
7:00AM Pacific Time
LOCATION
Poster Hall
PUBLICATION
NUMBER
2900
PRESENTERS
Sung Choe, PhD, Agios Pharmaceuticals, Inc, Cambridge, Massachusetts
ABSTRACT
617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III

SIGN UP FOR PRODUCT AND EVENT UPDATES
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CAPABILITIES
Why Single Cell SNV SNV + CNV DNA + Protein
APPLICATIONS
Oncology Research Multiple Myeloma AML MRD Precision Medicine Genome Editing Biomarker Development Cell and Gene Therapy
PRODUCTS & SERVICES
Tapestri Platform Panels Pharma Assay Development PAD for Cell & Gene Therapy PAD for Drug Development
COMPANY CAREERS NEWSROOM EVENTS BLOG RESOURCES SUPPORT CENTER CONTACT Terms of Use Privacy Policy Terms and Conditions of Sale Client Data Security & Retention
REQUEST QUOTE